A Single-Arm, Multicenter, Open-Label, Phase Ia/Ib Clinical Study of NW-301V in Advanced Solid Tumors Harboring KRAS G12V Mutations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07875920

Title field or adapter rule

{'original_value': 'A Single-Arm, Multicenter, Open-Label, Phase Ia/Ib Clinical Study of NW-301V in Advanced Solid Tumors Harboring KRAS G12V Mutations', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:23.317059+00:00

Published At

2026-10-15T00:00:00+00:00

Record Updated At

2026-10-15

Source Retrieved At

2026-10-31T22:17:52.415050+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Advanced Solid Cancer", "Pancreatic Ductal Adenocarcinoma (PDAC)", "Colorectal Adenocarcinoma", "Lung Adenocarcinoma", "KRAS G12V", "Pancreatic Cancer", "Colorectal Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-15", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07875920"

protocolSection.identificationModule.officialTitle

"A Single-Arm, Multicenter, Open-Label, Phase Ia/Ib Clinical Study of NW-301V in Advanced Solid Tumors Harboring KRAS G12V Mutations"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Advanced Solid Cancer (protocolSection.conditionsModule.conditions)
• Pancreatic Ductal Adenocarcinoma (PDAC) (protocolSection.conditionsModule.conditions)
• Colorectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
• KRAS G12V (protocolSection.conditionsModule.conditions)
• Pancreatic Cancer (protocolSection.conditionsModule.conditions)
• Colorectal Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['NW-301V'], 'description': 'Used for lymphodepletion', 'name': 'Fludarabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['NW-301V'], 'description': 'Used for lymphodepletion', 'name': 'Cyclophosphamide', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['NW-301V'], 'description': 'NW-301V is an autologous TCR-T cell therapy targeting KRAS G12V in the context of HLA-A\\*11:01, administered intravenously after lymphodepletion.', 'name': 'NW-301V', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Fludarabine (protocolSection.armsInterventionsModule.interventions[].name)
• Cyclophosphamide (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.